Cited by 11Neuroscience and Neuropharmacology ResearchStress Responses and CortisolNeurotransmitter Receptor Influence on Behavior

Dietary Phytochemicals Modulate Experience-Dependent Changes in Neurexin Gene Expression and Alternative Splicing in Mice after Chronic Variable Stress Exposure

Open access
Freire-Cobo, Carmen, Wang, Jun·2020·European Journal of Pharmacology

Abstract

Neurexins (NRXNs) are cell-adhesion molecules important in the formation and remodeling of neural circuits. It has been shown that aversive environmental stimuli can affect the expression pattern of Neurexin genes (Nrxns) impacting the regulation of synaptic strength. Accumulated evidence suggests that, after chronic exposure to psychological stress, the triggered changes in gene expression and splicing patterns of Nrxns may be involved in aversive conditioning. Previously, we have demonstrated that a novel treatment using dietary phytochemicals can modulate the response to chronic variable stress (CVS) in mice. Here, we aimed to further investigate the long-term plasticity changes after CVS by focusing on the regulation of NRXNs at synapses. We found that CVS differentially triggers the region-specific gene expression of Nrxns in mice Nucleus Accumbens (NAc) and Hippocampus (HIPP). The prophylactic treatment with the combination of two phytochemicals dihydrocaffeic acid (DHCA) and Malvidin-3-O-glucoside (Mal-gluc) differentially modulated the stress-induced effects on Nrxn1 and 3 mRNA expression in these brain areas and promoted the alternative splicing of Nrxn3 in HIPP. Overall, our data supports the prophylactic effect of dietary phytochemicals in the restoration of stress-induced plasticity changes in mouse brain. By intervening in activity-dependent plasticity at synapses, these compounds may attenuate the effects of chronic aversive conditioning. We propose that an early therapeutic intervention may help with disorders of negative affect, such as depression or post-traumatic stress disorder. Our future studies will address how DHCA/Mal-gluc might serve as a potential complement for current therapies in depression and other mood disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2020.173362

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Freire-Cobo, C., & Wang, J.
Affiliations
James J. Peters VA Medical Center (US)
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2020-09
Volume
883
Pages
173362
ISSN
0014-2999 (ISSN-L)
OpenAlex
W3042925427
Cited by
11
References
36
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2022: 2 · 2021: 2
FWCI
0.46
Type
journal article
Language
en
Open access
Locations
  • European Journal of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Center for Complementary and Integrative Health
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
dietary phytochemicals, neurexin, NRXN1, NRXN3, alternative splicing, chronic variable stress, dihydrocaffeic acid, malvidin-3-glucoside, nucleus accumbens, hippocampus, synaptic plasticity, aversive conditioning, depression, post-traumatic stress disorder, mood disorders, prophylaxis
MeSH terms
Animals, Anthocyanins, Behavior, Animal, Brain, Caffeic Acids, Calcium-Binding Proteins, Chronic Disease, Disease Models, Animal, Drug Therapy, Combination, Female, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Neuronal Plasticity, Neurons, Stress, Psychological, Synapses, Alternative Splicing, Neural Cell Adhesion Molecules, Phytochemicals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review